CompletedNCT00816894
D-serine or olanzapine for schizophrenia
About this title
Read the official source — NCT00816894Researchers compared D-serine and Olanzapine to find out how the approaches affected psychotic symptoms in people with schizophrenia.
Medication studyAges 18–70Israel
Understand this study
What did researchers investigate?
Researchers compared D-serine and Olanzapine to find out how the approaches affected psychotic symptoms in people with schizophrenia.
Who was this study for?
Listed age limits: 18 years to 70 years.
- Listed locations
- JerusalemSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Study information
Study start dateJanuary 2009
- Recruitment status
- Completed
- Enrollment listed in the registry
- 18
- Sponsor
- Herzog Hospital
- Sponsor type
- Hospital / academic medical center
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- Israel
- Age range
- From 18 Years to 70 Years
- Official registry ID
- NCT00816894
- Official title
Show the full official title
D-serine Antipsychotic Monotherapy for Treatment Refractory Schizophrenia
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Jerusalem
Interested in joining this study?
Questions about this study
What did researchers investigate?
Researchers compared D-serine and Olanzapine to find out how the approaches affected psychotic symptoms in people with schizophrenia.
Who is behind this study?
The study sponsor is Herzog Hospital, a hospital or academic medical center.
Did this study involve medication?
Yes. The study involved medication, including D-serine and Olanzapine.
Who was this study for?
Listed age limits: 18 years to 70 years.
